Cardio Diagnostics Holdings, Inc. (CDIO)
2.02
-0.01
(-0.49%)
USD |
NASDAQ |
Sep 18, 16:00
2.02
0.00 (0.00%)
After-Hours: 20:00
Cardio Diagnostics Holdings Cash from Investing (Quarterly) : -0.0468M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0468M |
| March 31, 2026 | -0.0637M |
| December 31, 2025 | -0.0784M |
| September 30, 2025 | -0.2578M |
| June 30, 2025 | -0.0357M |
| March 31, 2025 | -0.0474M |
| December 31, 2024 | -0.0546M |
| September 30, 2024 | -0.0786M |
| June 30, 2024 | -0.2011M |
| March 31, 2024 | -0.0699M |
| Date | Value |
|---|---|
| December 31, 2023 | -0.5669M |
| September 30, 2023 | -0.0871M |
| June 30, 2023 | -0.0876M |
| March 31, 2023 | -0.0527M |
| December 31, 2022 | -0.0025M |
| September 30, 2022 | -0.3269M |
| June 30, 2022 | -0.0222M |
| March 31, 2022 | -0.0164M |
| December 31, 2021 | -0.364M |
| September 30, 2021 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | 0.00 |
| Exicure, Inc. | 0.00 |
| Century Therapeutics, Inc. | 17.77M |
| Absci Corp. | 24.07M |
| Celularity, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.342M |
| Cash from Financing (Quarterly) | -0.1012M |
| Free Cash Flow | -6.106M |
| Free Cash Flow Per Share (Quarterly) | -0.4694 |
| Free Cash Flow to Equity (Quarterly) | -1.226M |
| Free Cash Flow to Firm (Quarterly) | -1.386M |
| Free Cash Flow Yield | -128.9% |